RetinalGenix Technologies (RTGN) Long-Term Deferred Tax (2020 - 2023)
RetinalGenix Technologies' (RTGN) quarterly Long-Term Deferred Tax came in at $3.3 million in Q4 2023, up 23.27% year-on-year from $2.7 million in Q4 2022, and up 23.27% quarter-over-quarter from $2.7 million in Q4 2022.
RetinalGenix Technologies (RTGN) Long-Term Deferred Tax (2020 - 2023) Analysis & Trends
RetinalGenix Technologies has disclosed Long-Term Deferred Tax across 4 years of filings, most recently posting $3.3 million for Q4 2023.
- Long-Term Deferred Tax for Q4 2023 came in at $3.3 million, up 23.27% year-over-year; the trailing twelve-month figure through Dec 2023 was $3.3 million (up 23.27% YoY), and the FY2023 annual result was $3.3 million, up 23.27% from the prior year.
- Long-Term Deferred Tax came in at $3.3 million for Q4 2023 at RetinalGenix Technologies, up from $2.7 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $3.3 million in Q4 2023 to a low of $789000.0 in Q4 2020.
- The 4-year median for Long-Term Deferred Tax is $1.9 million (2021), against an average of $2.0 million.
- Across the five-year window, Long-Term Deferred Tax jumped 125.48% in 2022 and gained 23.27% in 2023, its largest moves.
- RetinalGenix Technologies' Long-Term Deferred Tax stood at $789000.0 in 2020, then jumped by 51.2% to $1.2 million in 2021, then soared by 125.48% to $2.7 million in 2022, then gained by 23.27% to $3.3 million in 2023.
- The last three Long-Term Deferred Tax figures came in at $3.3 million (Q4 2023), $2.7 million (Q4 2022), and $1.2 million (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | RetinalGenix Technologies | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 3.32 Mn |
| Dec 31, 2022 | 2.69 Mn |
| Dec 31, 2021 | 1.19 Mn |
| Dec 31, 2020 | 789,000.00 |